KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 123 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $15,355,000 | +11.7% | 2,620,238 | +1.2% | 0.00% | 0.0% |
Q3 2016 | $13,746,000 | -13.9% | 2,588,613 | +7.3% | 0.00% | -33.3% |
Q2 2016 | $15,974,000 | +30.2% | 2,413,012 | -8.2% | 0.00% | +50.0% |
Q1 2016 | $12,270,000 | -7.4% | 2,627,474 | +0.2% | 0.00% | 0.0% |
Q4 2015 | $13,248,000 | +47.7% | 2,623,417 | +3.0% | 0.00% | 0.0% |
Q3 2015 | $8,967,000 | -63.9% | 2,547,411 | +2.4% | 0.00% | -50.0% |
Q2 2015 | $24,818,000 | -25.4% | 2,486,812 | -4.8% | 0.00% | -20.0% |
Q1 2015 | $33,256,000 | -2.9% | 2,612,394 | +8.0% | 0.01% | 0.0% |
Q4 2014 | $34,234,000 | -2.0% | 2,419,339 | -4.8% | 0.01% | -16.7% |
Q3 2014 | $34,938,000 | -11.1% | 2,540,927 | -0.5% | 0.01% | -14.3% |
Q2 2014 | $39,281,000 | -10.0% | 2,554,011 | -0.3% | 0.01% | -12.5% |
Q1 2014 | $43,630,000 | +40.8% | 2,560,460 | +7.0% | 0.01% | +60.0% |
Q4 2013 | $30,996,000 | +26.2% | 2,393,507 | -1.7% | 0.01% | 0.0% |
Q3 2013 | $24,564,000 | +44.0% | 2,434,465 | +6.6% | 0.01% | +66.7% |
Q2 2013 | $17,061,000 | – | 2,283,893 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |